- Home
-
Research
Development -
Community
Engagement -
Scientific
Translation -
Human
Studies -
Informatics
Biostatistics -
Education
Training -
Research
Ethics -
Regulatory
Support
|
|
|
To improve health in the diverse urban environment of Los Angeles and, in doing so, to gain knowledge that we can share with others to improve health in urban settings and megacities across the globe.
To transform our academic-clinical-community partnership into a pre-eminent clinical and translational science institute focused on better health for diverse, urban communities.
USC is known for its innovation and entrepreneurship; linking fundamental and applied research; spanning disciplinary boundaries; building networks and partnerships with the community; and increasing responsiveness to learners. Clinical researchers have partnered with our local communities to produce major advances in health and with other disciplines to create novel technical approaches to real-world health problems. USC has a strong tradition in population research and is located in the urban heart of the Los Angeles metropolitan area that is home to one of every 21 Americans.
USC now partners with leading academic, clinical, and community partners in Central Los Angeles to create the Los Angeles Basin-Clinical and Translational Science Institute (LAB-CTSI). It is through these partnerships that the LAB-CTSI is able to generate new research ideas, teams and projects, and create an environment that promotes and supports the conduct and dissemination of translational research.
The LAB-CTSI offers a wide variety of resources to support the development and conduct of clinical and translational research. The resources are organized into two offices: Research Development and Community Engagement; four centers: Scientific Translation, Human Studies, Education, and Biomedical Informatics; and three programs Regulatory, Ethics, and Tracking and Evaluation.
Dr. Buchanan is Professor of Medicine, OB/Gyn and Physiology/Biophysics in the Keck School of Medicine. Scientifically, he merged mechanistic and clinical studies to optimize information about type 2 diabetes biology, detection, and prevention in Hispanic Americans. Dr. Buchanan built and directs one of the largest General Clinical Research Centers (GCRC) in the United States. He is past president of the GCRC Program Directors Association. He is the Associate Dean for Clinical Research at the Keck School of Medicine, co-chairs the Faculty Research Council, and is the CTSI Director.
Dr. Kipke is Professor of Pediatrics and Preventive Medicine at the Keck School of Medicine, housed at Childrens Hospital Los Angeles (CHLA). She directs clinical and community research focused on understanding and modifying risk behaviors and reducing risk of at-risk and vulnerable pediatric populations. She heads the Community, Health Outcomes, and Intervention Research program at CHLA.
Dr. Pato is Professor and Chair of Psychiatry in the Keck School of Medicine at USC and a leading geneticist in mental illness. Dr. Pato co-leads the Genomic Cohort, has experience as an Associate Dean of Clinical Affairs, Associate Chief of Staff for Research, and a program director for NIH. He has been a leader in collaborative projects in neuroscience across CTSI partners.